title: Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal.
abstract: At 3-5 years of age, female recipients of Edmonston-Zagreb high-titre (EZ-HT) and Schwarz high-titre (SW-HT) measles vaccine had lower survival rates than female recipients of Schwarz standard measles vaccine (SW-STD) in Guinea-Bissau, Senegal and Haiti. In Senegal, the children who received high-titre vaccines have now been followed to the age of 5-7 years to determine whether the difference in mortality persisted, and whether differences in vaccine efficacy were apparent. At this age there was no difference in mortality between female recipients of high-titre and standard titre measles vaccines. There was no indication that high-titre EZ-HT vaccine at 5 months (EZ-HT,5m) provided suboptimal protection, as vaccine efficacy after exposure was 97% and 95%, respectively, for EZ-HT,5m and SW-STD,10m vaccines, whereas SW-HT,5m vaccine had an efficacy of 81%. The difference in mortality between recipients of high-titre vaccines and SW-STD observed in several studies during the first few years after vaccination may be explained by non-specific beneficial effects of the standard measles vaccine rather than a harmful effect of the high-titre vaccines.
authors.affiliation: UR Maladies Infectieuses et Parasitaires, ORSTOM, Dakar, Senegal.
authors.forename: P
authors.initials: P
authors.lastname: Aaby
authors.forename: B
authors.initials: B
authors.lastname: Samb
authors.forename: F
authors.initials: F
authors.lastname: Simondon
authors.forename: K
authors.initials: K
authors.lastname: Knudsen
authors.forename: A M
authors.initials: AM
authors.lastname: Seck
authors.forename: J
authors.initials: J
authors.lastname: Bennett
authors.forename: L
authors.initials: L
authors.lastname: Markowitz
authors.forename: H
authors.initials: H
authors.lastname: Whittle
mesh_terms: D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007114:Immunization; D007223:Infant; D008297:Male; D008457:Measles / Q000453:epidemiology / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage*; D009017:Morbidity; D009026:Mortality; D012675:Senegal
chemical_list: D008458:Measles Vaccine